4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001567619-19-021771
Options or other derivatives
- Chief Legal Officer acquired 84,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Walker Robin A. · Chief Legal Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-11-15 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +84,800 | $23.32 | 2029-11-14 | 84,800 | 84,800 | D |
Loading xslF345X03/doc1.xml…